Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
Barrett
M
M
Department of Nuclear Medicine, King's College Hospital, London, England.
Milton
A D
AD
Barrett
J
J
Taube
D
D
Bewick
M
M
Parsons
V P
VP
Fabre
J W
JW
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001707:Biopsy, Needle; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005802:Genes, MHC Class II; D006084:Graft Rejection / Q000187:drug effects / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D000949:Histocompatibility Antigens Class II; D011239:Prednisolone